Table 2.
Proportions of Subjects with Detectable Dengue-specific CD4+ T cell Cytokine Production from Presecondary Infection PBMC for Subclinical and Symptomatic Groups
No. of responders: no. of nonresponders |
||||
Cytokine | Antigen | SubclinicalSamples | Symptomatic Samples | P (by Fisher's exact test) |
TNFα | D1 | 14:3 | 6:4 | .36 (NS) |
D2 | 11:6 | 10:0 | .06 | |
D3 | 7:10 | 1:9 | .19 (NS) | |
D4 | 16:1 | 8:2 | .54 (NS) | |
IFNγ | D1 | 5:12 | 1:9 | .36 (NS) |
D2 | 8:9 | 2:8 | .23 (NS) | |
D3 | 7:10 | 1:9 | .19 (NS) | |
D4 | 8:9 | 0:10 | .01 | |
IL-2 | D1 | 4:13 | 0:10 | .26 (NS) |
D2 | 10:7 | 2:8 | .11(NS) | |
D3 | 5:12 | 1:9 | .36 (NS) | |
D4 | 8:9 | 0:10 | .01 |
NOTE. NS, not statistically significant difference in proportions.